R. Hector MacKay-Dunn, Director at Aurinia Pharmaceuticals Inc. (AUPH), bought 4,500 shares at $11.17 ($51K) on 2021-05-11, disclosed to the SEC on 2021-05-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.14 | 1,000 | $11K | 22.0% |
| 2 | $11.17 | 500 | $6K | 11.1% |
| 3 | $11.26 | 1,400 | $16K | 31.2% |
| 4 | $11.28 | 1,600 | $18K | 35.7% |
| Total | $11.23 avg | 4,500 | $51K | 100% |
| Filing → |
| AUPH | BUY | 2022-03-11 | $55K | — | Filing → |